Business Context and Reporting Period
This Form 8-K Current Report was filed by American Vanguard Corporation on January 5, 2009. The report concerns the appointment of a new executive officer at Amvac Chemical Corporation, the registrant's principal operating subsidiary.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation and appointment details.
Material Changes
Effective January 5, 2009, the Corporation appointed Trevor Thorley as Executive Vice President and Chief Operating Officer of Amvac Chemical Corporation. This is a newly created position. Mr. Thorley, age 51, was selected through a retained search and previously served as President and Chief Operating Officer of Valent USA Corporation.
Compensation and Employment Terms
- Base Salary: $372,000 annually.
- Contract Term: Three years.
- Severance (Termination without cause): The greater of (x) annual base salary for the remainder of the term (capped at two years) or (y) one year's base salary.
- Equity Award: 8,347 shares of restricted stock, vesting in equal tranches over three years.
- Change in Control: If terminated without cause following a Change in Control before December 31, 2013, Mr. Thorley is entitled to two times his base annual salary, 24 months of medical benefits, and acceleration of securities rights.
Investor Verification Checklist
- Verify the full text of the press release attached as Exhibit 99.1 for additional context on the appointment.
- Confirm the vesting schedule details in the Restricted Stock Agreement referenced in the filing.
- Review the definition of "Change in Control" within the Change in Control Severance Agreement to understand the specific triggers for enhanced severance.
- Note that this filing does not provide updated financial results; refer to the most recent 10-K or 10-Q for financial metrics.